(ADI) Analog Devices - Overview
Sector: TechnologyIndustry: Semiconductors | Exchange NASDAQ (USA) | Currency USD | Market Cap: 153.013m | Total Return 54.8% in 12m
Stock: ICs, Software, Subsystems
Total Rating 65
Risk 80
Buy Signal -0.15
| Risk 5d forecast | |
|---|---|
| Volatility | 35.5% |
| Relative Tail Risk | -4.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 29.47 |
| Character TTM | |
|---|---|
| Beta | 1.701 |
| Beta Downside | 1.741 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.20% |
| CAGR/Max DD | 0.56 |
EPS (Earnings per Share)
Revenue
Description: ADI Analog Devices March 04, 2026
Analog Devices, Inc. (ADI) designs, manufactures, tests, and markets integrated circuits (ICs), software, and subsystem products globally. The companys product portfolio includes data converters, power management ICs, amplifiers, radio frequency and microwave ICs, and micro-electro-mechanical systems (MEMS) technology solutions. These products serve diverse markets such as industrial, automotive, consumer, and communications.
The semiconductor industry is characterized by high R&D investment and rapid technological advancement. Semiconductor companies typically operate with a fabless, IDM (integrated device manufacturer), or foundry business model. ADI utilizes a direct sales force, distributors, and online channels for product distribution.
To deepen your understanding of ADIs competitive landscape and financial performance, consider exploring detailed analytics on ValueRay.
Headlines to watch out for
- Industrial automation demand drives analog chip sales
- Automotive electrification boosts semiconductor content
- Communications infrastructure spending impacts RF product revenue
- Global economic slowdown reduces consumer electronics demand
- Supply chain disruptions affect manufacturing costs and delivery
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 2.71b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.86 > 1.0 |
| NWC/Revenue: 27.83% < 20% (prev 29.58%; Δ -1.75% < -1%) |
| CFO/TA 0.11 > 3% & CFO 5.05b > Net Income 2.71b |
| Net Debt (5.78b) to EBITDA (5.52b): 1.05 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (491.7m) vs 12m ago -1.41% < -2% |
| Gross Margin: 62.84% > 18% (prev 0.57%; Δ 6.23k% > 0.5%) |
| Asset Turnover: 24.50% > 50% (prev 19.47%; Δ 5.04% > 0%) |
| Interest Coverage Ratio: 10.80 > 6 (EBITDA TTM 5.52b / Interest Expense TTM 328.8m) |
Altman Z'' 2.48
| A: 0.07 (Total Current Assets 7.60b - Total Current Liabilities 4.33b) / Total Assets 47.99b |
| B: 0.23 (Retained Earnings 10.89b / Total Assets 47.99b) |
| C: 0.07 (EBIT TTM 3.55b / Avg Total Assets 47.98b) |
| D: 0.76 (Book Value of Equity 10.82b / Total Liabilities 14.20b) |
| Altman-Z'' Score: 2.48 = A |
Beneish M -3.08
| DSRI: 0.91 (Receivables 1.36b/1.19b, Revenue 11.76b/9.34b) |
| GMI: 0.91 (GM 62.84% / 57.16%) |
| AQI: 0.95 (AQ_t 0.77 / AQ_t-1 0.81) |
| SGI: 1.26 (Revenue 11.76b / 9.34b) |
| TATA: -0.05 (NI 2.71b - CFO 5.05b) / TA 47.99b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of ADI shares?
As of March 30, 2026, the stock is trading at USD 307.44 with a total of 3,280,891 shares traded.
Over the past week, the price has changed by -1.52%, over one month by -13.32%, over three months by +11.89% and over the past year by +54.78%.
Over the past week, the price has changed by -1.52%, over one month by -13.32%, over three months by +11.89% and over the past year by +54.78%.
Is ADI a buy, sell or hold?
Analog Devices has received a consensus analysts rating of 4.13.
Therefore, it is recommended to buy ADI.
- StrongBuy: 16
- Buy: 5
- Hold: 9
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the ADI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 384.5 | 25.1% |
| Analysts Target Price | 384.5 | 25.1% |
ADI Fundamental Data Overview March 28, 2026
P/E Trailing = 57.1934
P/E Forward = 26.5957
P/S = 13.0149
P/B = 4.4711
P/EG = 0.7696
Revenue TTM = 11.76b USD
EBIT TTM = 3.55b USD
EBITDA TTM = 5.52b USD
Long Term Debt = 7.24b USD (from longTermDebt, last quarter)
Short Term Debt = 1.44b USD (from shortTermDebt, last quarter)
Debt = 8.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.78b USD (from netDebt column, last quarter)
Enterprise Value = 157.65b USD (153.01b + Debt 8.68b - CCE 4.05b)
Interest Coverage Ratio = 10.80 (Ebit TTM 3.55b / Interest Expense TTM 328.8m)
EV/FCF = 34.57x (Enterprise Value 157.65b / FCF TTM 4.56b)
FCF Yield = 2.89% (FCF TTM 4.56b / Enterprise Value 157.65b)
FCF Margin = 38.79% (FCF TTM 4.56b / Revenue TTM 11.76b)
Net Margin = 23.02% (Net Income TTM 2.71b / Revenue TTM 11.76b)
Gross Margin = 62.84% ((Revenue TTM 11.76b - Cost of Revenue TTM 4.37b) / Revenue TTM)
Gross Margin QoQ = 64.71% (prev 63.13%)
Tobins Q-Ratio = 3.28 (Enterprise Value 157.65b / Total Assets 47.99b)
Interest Expense / Debt = 0.99% (Interest Expense 86.3m / Debt 8.68b)
Taxrate = 12.16% (115.0m / 945.9m)
NOPAT = 3.12b (EBIT 3.55b * (1 - 12.16%))
Current Ratio = 1.76 (Total Current Assets 7.60b / Total Current Liabilities 4.33b)
Debt / Equity = 0.26 (Debt 8.68b / totalStockholderEquity, last quarter 33.79b)
Debt / EBITDA = 1.05 (Net Debt 5.78b / EBITDA 5.52b)
Debt / FCF = 1.27 (Net Debt 5.78b / FCF TTM 4.56b)
Total Stockholder Equity = 34.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.64% (Net Income 2.71b / Total Assets 47.99b)
RoE = 7.92% (Net Income TTM 2.71b / Total Stockholder Equity 34.17b)
RoCE = 8.57% (EBIT 3.55b / Capital Employed (Equity 34.17b + L.T.Debt 7.24b))
RoIC = 7.35% (NOPAT 3.12b / Invested Capital 42.46b)
WACC = 11.37% (E(153.01b)/V(161.70b) * Re(11.97%) + D(8.68b)/V(161.70b) * Rd(0.99%) * (1-Tc(0.12)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.71%
[DCF] Terminal Value 66.91% ; FCFF base≈4.01b ; Y1≈3.98b ; Y5≈4.15b
[DCF] Fair Price = 79.34 (EV 44.51b - Net Debt 5.78b = Equity 38.73b / Shares 488.2m; r=11.37% [WACC]; 5y FCF grow -1.58% → 3.0% )
EPS Correlation: -57.77 | EPS CAGR: -8.93% | SUE: 0.83 | # QB: 0
Revenue Correlation: -32.32 | Revenue CAGR: 1.65% | SUE: 1.07 | # QB: 8
EPS next Quarter (2026-04-30): EPS=2.90 | Chg7d=+0.001 | Chg30d=+0.453 | Revisions Net=+23 | Analysts=26
EPS current Year (2026-10-31): EPS=11.43 | Chg7d=-0.029 | Chg30d=+1.427 | Revisions Net=+29 | Growth EPS=+46.7% | Growth Revenue=+26.8%
EPS next Year (2027-10-31): EPS=12.93 | Chg7d=+0.030 | Chg30d=+1.435 | Revisions Net=+26 | Growth EPS=+13.1% | Growth Revenue=+9.3%
[Analyst] Revisions Ratio: +1.00 (23 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.2% (Discount Rate 12.0% - Earnings Yield 1.7%)
[Growth] Growth Spread = +22.8% (Analyst 33.0% - Implied 10.2%)
P/E Forward = 26.5957
P/S = 13.0149
P/B = 4.4711
P/EG = 0.7696
Revenue TTM = 11.76b USD
EBIT TTM = 3.55b USD
EBITDA TTM = 5.52b USD
Long Term Debt = 7.24b USD (from longTermDebt, last quarter)
Short Term Debt = 1.44b USD (from shortTermDebt, last quarter)
Debt = 8.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.78b USD (from netDebt column, last quarter)
Enterprise Value = 157.65b USD (153.01b + Debt 8.68b - CCE 4.05b)
Interest Coverage Ratio = 10.80 (Ebit TTM 3.55b / Interest Expense TTM 328.8m)
EV/FCF = 34.57x (Enterprise Value 157.65b / FCF TTM 4.56b)
FCF Yield = 2.89% (FCF TTM 4.56b / Enterprise Value 157.65b)
FCF Margin = 38.79% (FCF TTM 4.56b / Revenue TTM 11.76b)
Net Margin = 23.02% (Net Income TTM 2.71b / Revenue TTM 11.76b)
Gross Margin = 62.84% ((Revenue TTM 11.76b - Cost of Revenue TTM 4.37b) / Revenue TTM)
Gross Margin QoQ = 64.71% (prev 63.13%)
Tobins Q-Ratio = 3.28 (Enterprise Value 157.65b / Total Assets 47.99b)
Interest Expense / Debt = 0.99% (Interest Expense 86.3m / Debt 8.68b)
Taxrate = 12.16% (115.0m / 945.9m)
NOPAT = 3.12b (EBIT 3.55b * (1 - 12.16%))
Current Ratio = 1.76 (Total Current Assets 7.60b / Total Current Liabilities 4.33b)
Debt / Equity = 0.26 (Debt 8.68b / totalStockholderEquity, last quarter 33.79b)
Debt / EBITDA = 1.05 (Net Debt 5.78b / EBITDA 5.52b)
Debt / FCF = 1.27 (Net Debt 5.78b / FCF TTM 4.56b)
Total Stockholder Equity = 34.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.64% (Net Income 2.71b / Total Assets 47.99b)
RoE = 7.92% (Net Income TTM 2.71b / Total Stockholder Equity 34.17b)
RoCE = 8.57% (EBIT 3.55b / Capital Employed (Equity 34.17b + L.T.Debt 7.24b))
RoIC = 7.35% (NOPAT 3.12b / Invested Capital 42.46b)
WACC = 11.37% (E(153.01b)/V(161.70b) * Re(11.97%) + D(8.68b)/V(161.70b) * Rd(0.99%) * (1-Tc(0.12)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.71%
[DCF] Terminal Value 66.91% ; FCFF base≈4.01b ; Y1≈3.98b ; Y5≈4.15b
[DCF] Fair Price = 79.34 (EV 44.51b - Net Debt 5.78b = Equity 38.73b / Shares 488.2m; r=11.37% [WACC]; 5y FCF grow -1.58% → 3.0% )
EPS Correlation: -57.77 | EPS CAGR: -8.93% | SUE: 0.83 | # QB: 0
Revenue Correlation: -32.32 | Revenue CAGR: 1.65% | SUE: 1.07 | # QB: 8
EPS next Quarter (2026-04-30): EPS=2.90 | Chg7d=+0.001 | Chg30d=+0.453 | Revisions Net=+23 | Analysts=26
EPS current Year (2026-10-31): EPS=11.43 | Chg7d=-0.029 | Chg30d=+1.427 | Revisions Net=+29 | Growth EPS=+46.7% | Growth Revenue=+26.8%
EPS next Year (2027-10-31): EPS=12.93 | Chg7d=+0.030 | Chg30d=+1.435 | Revisions Net=+26 | Growth EPS=+13.1% | Growth Revenue=+9.3%
[Analyst] Revisions Ratio: +1.00 (23 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.2% (Discount Rate 12.0% - Earnings Yield 1.7%)
[Growth] Growth Spread = +22.8% (Analyst 33.0% - Implied 10.2%)